← FDA DRUG APPROVALS

FDA ANDA · ANDA078537

FOMEPIZOLE

Sponsor: NAVINTA LLC

APPLICATION
ANDA078537
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-06
LATEST ACTION
2020-12-23
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FOMEPIZOLEPrescription
FOMEPIZOLE 1.5GM/1.5ML (1GM/ML) · INJECTABLE · INJECTION

Approval history

2020-12-23Labeling · Supplement 8 · standardAP
2016-04-22Manufacturing (CMC) · Supplement 4 · unknownAP
2015-03-18Labeling · Supplement 2AP
2008-03-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →